Evolution of prenatal detection of neural tube defects in the pregnant population of the city of Barcelona from 1992 to 2006

Prenatal Diagnosis

Volumn 31, Issue 12, 2011, Pages 1184-1188

  Salvador, Joaquín ^a,b   Arigita, Marta ^c   Carreras, Elena ^d   Lladonosa, Anna ^e   Borrell, Antoni ^c  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e ADKNOMA Health Research SL   (Spain)

Author keywords

Anencephaly; First trimester ultrasound; Neural tube defects; Prenatal diagnosis; Spina bifida; Ultrasound screening

Indexed keywords

ANENCEPHALUS; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; ENCEPHALOCELE; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR EVOLUTION; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REGISTER; SPAIN; SPINA BIFIDA;

FEMALE; HUMANS; INFANT, NEWBORN; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY TRIMESTERS; SPAIN; ULTRASONOGRAPHY, PRENATAL;

EID: 82255175618     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2863     Document Type: Article

References (36)

1. Adetiloye VA, Dare FO, Oyelami OA. 1993. A ten-year review of encephalocele in a teaching hospital. Int J Gynaecol Obstet 41: 241-249.
2. Adzick NS, Thom EA, Spong CY, et al. 2011. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364(11): 993-1004.
3. Borrell A, Casals E, Fortuny A, et al. 2004. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 24(7): 541-545.
4. Boyd PA, Wellesley DG, De Walle HE, et al. 2000. Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen 7: 169-174.
5. Budorick NE, Pretorius DH, McGahan JP, Grafe MR, James HE, Slivka J. 1995. Cephalocele detection in utero: sonographic and clinical features. Ultrasound Obstet Gynecol 5: 77-85.
6. Chan A, Robertson EF, Haan EA, Ranieri E, Keane RJ. 1995. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991. Br J Obstet Gynaecol 102: 370-376.
7. Coll O, Pisa S, Palacio M, Quintó L, Cararach V. 2004. Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area. Eur J Obstet Gynecol Reprod Biol 115(2): 173-177.
8. Czeizel AE, Dudás I. 1992. Prevention of the first ocurrence of neural-tube defects by periconcepcional vitamin supplementation. N Engl J Med 327: 1832-1835.
9. Dashe JS, Twickler DM, Santos-Ramos R, McIntire DD, Ramus RM. 2006. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound. Am J Obstet Gynecol 195: 1623-1628.
10. De Wals P, Trochet C, Pinsonneault L. 1999. Prevalence of neural tube defects in the province of Quebec, 1992. Can J Public Health 90: 237-239.
11. DSSS. Departament de Sanitat i Seguretat Social. Generalitat de Catalunya. 1997. Programa de Diagnostic Prenatal d'anomalies congènites a Catalunya. Barcelona.
12. EUROCAT Website database. [Accessed on 01 July 2011].
13. Forrester MB, Merz RD. 2000. Prenatal diagnosis and elective termination of neural tube defects in Hawaii, 1986-1997. Fetal Diagn Ther 15: 146-151
14. Forrester MB, Merz RD, Yoon PW. 1998. Impact of prenatal diagnosis and elective termination on the prevalence of selected birth defects in Hawaii. Am J Epidemiol 148: 1206-1211.
15. Grandjean H, Larroque D, Levi S. 1999. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 181(2): 446-454.
16. Johnson SP, Sebire NJ, Snijders RJ, Tunkel S, Nicolaides KH. 1997. Ultrasound screening for anencephaly at 10-14weeks of gestation. Ultrasound Obstet Gynecol 9: 14-16.
17. Jorgensen FS, Valentin L, Salvesen KA, et al. 1999. MULTISCAN - A Scandinavianmulticenter second trimester obstetric ultrasound and serum screening study. Acta Obstet Gynecol Scand 78: 501-510.
18. Lys F, De Wals P, Borlee-Grimee I, Billiet A, Vincotte-Mols M, Levi S. 1989. Evaluation of routine ultrasound examination for the prenatal diagnosis of malformation. Eur J Obstet Gynecol Reprod Biol 30: 101-109.
19. MCR Vitamin Study Research Group. 1991. Prevention of neural tube defects: Results of the MCR Vitamin Study. Lancet 338: 131-137.
20. MSC. Ministerio de Sanidad y Consumo. 1991. Manual de diagnostico prenatal para sanitarios. Madrid.
21. Nicolaides KH, Campbell S, Gabbe SG, Guidetti R. 1986. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 2(8498): 72-74.
22. Nikkilä A, Rydhström H, Källén B. 2006. The incidence of spina bifida in Sweden 1973-2003: the effect of prenatal diagnosis. Eur J Public Health 16(6): 660-662.
23. Norem CT, Schoen EJ, Walton DL, et al. 2005. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol 106: 747-752.
24. Olde Scholtenhuis MA, Cohen-Overbeek TE, Offringa M, et al. 2003. Audit of prenatal and postnatal diagnosis of isolated open spina bifida in three university hospitals in The Netherlands. Ultrasound Obstet Gynecol 21: 48-52.
25. Rankin J, Glinianaia S, Brown R, Renwick M. 2000. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-96. Northern Congenital Abnormality Survey Steering Group. Paediatr Perinat Epidemiol 14: 104-110.
26. Romero R, Mathisen JM, Ghidini A, Sirtori M, Hobbins JC. 1989. Accuracy of ultrasound in the prenatal diagnosis of spinal anomalies. Am J Perinatol 6: 320-323.
27. Salvador J, García-Miñaur S, Caballín MR, et al. 1998. Registros poblacionales de defectos congénitos en España. An Esp Pediatr 48: 575-582.
28. Salvador J, Borrell A, Lladonosa A. 2005. Increasing detection rates of birth defects by prenatal ultrasound leading to apparent increasing prevalence. Lessons learned from the population-based registry of birth defects of Barcelona. Prenat Diagn 25: 991-996.
29. Salvador J, Cunillé M, Ricart M, Roig A. Informe anual. 2007. Registre de Defectes Congènits de la ciutat de Barcelona (REDCB).
30. Smithells RW, Sheppard S, Wild J. 1989. Prevalence of neural tube defects in the Yorkshire Region. Community Med 11: 163-167.
31. Stoll C, Alembik Y, Dott B, Roth MP. 2002. Impact of prenatal diagnosis on livebirth prevalence of children with congenital anomalies. Ann Genet 45: 115-121.
32. Van Allen MI, Boyle E, Thiessen P, et al. 2006. The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia. J Appl Genet 47: 151-158.
33. Wald NJ, Oakley GP. 2007 Should folic acid fortification be mandatory? Yes. BMJ 334(7606): 1252.
34. Wald NJ, Brock DJ, Bonnar J. 1974. Prenatal diagnosis of spina bifida and anencephaly by maternal serum-alpha-fetoprotein measurement. A controlled study. Lancet 1(7861): 765-767.
35. Whitlow BJ, Chatzipapas IK, Lazanakis ML, Kadir RA, Economides DL. 1999. The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population. Br J Obstet Gynaecol 106(9): 929-936.
36. Winsor EJ, Brown BS. 1986. Prevalence and prenatal diagnosis of neural tube defects in Nova Scotia in 1980-84. CMAJ 135: 1269-1273.